Literature DB >> 28160966

Influence of intraoperative radiation therapy on locally advanced and recurrent colorectal tumors: A 16-year experience.

Justin T Brady1, Benjamin P Crawshaw2, Barrington Murrell3, Eslam M G Dosokey2, Murad A Jabir2, Scott R Steele2, Sharon L Stein2, Harry L Reynolds4.   

Abstract

BACKGROUND: Intraoperative radiation therapy (IORT) has been proposed as a tool to improve local control in patients with locally advanced primary or recurrent colorectal cancer.
METHODS: A retrospective review (1999-2015) of all patients undergoing IORT for locally advanced or recurrent colorectal cancer at a single academic center was performed. Patient demographics, oncologic staging, short-term and long-term outcomes were reviewed.
RESULTS: There were 77 patients (mean age 63 ± 11 years) identified, of whom 19 had colon cancer, 57 had rectal cancer, and 2 had appendiceal cancers. R0 resection was performed in 53 patients (69%), R1 in 19 (25%) and R2 in 5 (6%). Ten (13%) patients had a local recurrence at 18 ± 14 months and 34 (44%) had a distant recurrence at 18 ± 18 months. Mean survival was 47 ± 41 months.
CONCLUSION: IORT resulted in low local failure rates and should be considered for patients with locally advanced or recurrent colorectal cancers.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Colorectal; Radiation

Mesh:

Year:  2017        PMID: 28160966     DOI: 10.1016/j.amjsurg.2016.10.036

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

Review 1.  ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer.

Authors:  Felipe A Calvo; Claudio V Sole; Harm J Rutten; Wim J Dries; Miguel A Lozano; Mauricio Cambeiro; Philip Poortmans; Luis González-Bayón
Journal:  Clin Transl Radiat Oncol       Date:  2020-06-17

2.  Low-kilovolt x-ray intraoperative radiotherapy for pT3 locally advanced colon cancer: a single-institution retrospective analysis.

Authors:  Li Ma; Junhao Qiang; Heliang Yin; Lin Lin; Yan Jiao; Changying Ma; Xinwei Li; Li Dong; Jinglin Cui; Dongmei Wei; Ankur M Sharma; David L Schwartz; Weikuan Gu; Hong Chen
Journal:  World J Surg Oncol       Date:  2020-06-17       Impact factor: 2.754

3.  Initial clinical experience using a novel Pd-103 surface applicator for the treatment of retroperitoneal and abdominal wall malignancies.

Authors:  Heming Zhen; Julius V Turian; Neilayan Sen; Minh B Luu; Ross A Abrams; Dian Wang
Journal:  Adv Radiat Oncol       Date:  2017-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.